Canadian Supreme Court decision on GlaxoSmithKline's transfer pricing

The Canadian Supreme Court (SC) has today delivered its first transfer pricing decision, in a case involving GlaxoSmithKline (GSK).
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: